Affinnova, Inc.

Ideal VP Picks for Presidential Candidates to Be Identified With Evolutionary Optimization Software

Ideal VP Picks for Presidential Candidates to Be Identified With Evolutionary Optimization Software

June 16, 2008

"Secret weapon" technology of major consumer goods companies will search through millions of variations of candidates and issues, rapidly evolving the ideal presidential ticket

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals Named One of the “Fierce 15" Biotech Companies of 2008

Concert Pharmaceuticals Named One of the “Fierce 15" Biotech Companies of 2008

June 24, 2008

Lexington, MA (June 24, 2008) – Concert Pharmaceuticals, Inc. announced today that it has been named to the annual FierceBiotech “Fierce 15” list, designating it as one of the top biotechnology companies of 2008. The editors of FierceBiotech evaluated hundreds of privately-held firms based on a variety of factors including company vision, strength of technology, and competitive market position. A complete list of ‘Fierce 15’ companies is available in today’s issue of FierceBiotech and on the FierceBiotech Web site at www.fiercebiotech.com.

Mascoma Corporation

Granholm Says Mascoma Agreement Puts Michigan at Forefront of Next Generation Fuels

Granholm Says Mascoma Agreement Puts Michigan at Forefront of Next Generation Fuels

June 27, 2008

Historic investment set for production facility in U.P.’s Chippewa County

LANSING – Governor Jennifer M. Granholm and Mascoma Corporation CEO Bruce A. Jamerson today announced that the Massachusetts-based company has entered into a series of key strategic relationships to further Mascoma’s efforts to build its first commercial-scale cellulosic ethanol plant in Michigan’s Upper Peninsula.

Affinnova, Inc.

Powell Tops Democratic and Republican VP Candidates as Evolutionary Optimization Software Identifies Ideal 2008 Presidential Tickets

Powell Tops Democratic and Republican VP Candidates as Evolutionary Optimization Software Identifies Ideal 2008 Presidential Tickets

June 30, 2008

Surprise findings include Edwards, Clinton and Giuliani losing ground with likely voters due to polarizing appeal; economy is a top issue, Iraq War is not

Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals Closes $33 Million Series A Funding

Agios Pharmaceuticals Closes $33 Million Series A Funding

July 7, 2008

Company Founded by Pioneers in Emerging Field of Cancer Metabolism

Accuri Cytometers, Inc.

Accuri Cytometers Completes $13 Million Series C Financing

Accuri Cytometers Completes $13 Million Series C Financing

July 8, 2008

New Funds will Support Expanded Commercialization of the Revolutionary Accuri C6 Flow Cytometer® System

BG Medicine, Inc.

BG Medicine Closes $40 Million in Series D Financing

BG Medicine Closes $40 Million in Series D Financing

July 17, 2008

Funds to accelerate launch of diagnostic products to enable Biomarker-Guided Medicine

Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals Completes Series A Financing to Support the Advancement of Breakthrough Synthetic Chemistry Platform

Tetraphase Pharmaceuticals Completes Series A Financing to Support the Advancement of Breakthrough Synthetic Chemistry Platform

August 6, 2008

Raises $15M to Close Second Tranche of $25M Financing

WATERTOWN, Mass., Aug 06, 2008 (BUSINESS WIRE) -- Tetraphase Pharmaceuticals Inc. announced today that it has closed the second tranche of its $25 million Series A financing to support the advancement of several novel and potent antibiotic drug candidates. This second tranche of $15 million was funded by existing investors - Mediphase Venture Partners, CMEA Ventures, Fidelity Biosciences, Flagship Ventures and Skyline Ventures.

Affinnova, Inc.

Affinnova’s New Client Gains and Increasing Frequency Propel Sales Up 63%

Affinnova’s New Client Gains and Increasing Frequency Propel Sales Up 63%

August 11, 2008

Affinnova Announces First Half 2008 Results

Waltham, MA – August 11, 2008 – Affinnova, Inc., the global leader in optimization technology for innovation and marketing, today announced growth results for the first half ended June 30, 2008.

First Half Highlights

Affinnova grew sales for the first half ended June 30, 2008 by 63% compared to the first half of 2007, an increase of 25% compared to the second half of 2007.

Quanterix Corporation

Quanterix Corporation Raises $15 Million in Series A Financing

Quanterix Corporation Raises $15 Million in Series A Financing

August 26, 2008

Leader in single molecule detection will utilize funds to advance SiMoA™ technology